Northeast Pharmaceutical Group Co., Ltd. (000597.SZ)
CNY 5.44
(0.18%)
CNY 5.44
(0.18%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 586.75 Million | 1.1 Billion | 746.5 Million | 570.91 Million | 352.59 Million | 285.09 Million |
| Net Income | 358.45 Million | 357.04 Million | 95.44 Million | 10.82 Million | 170.44 Million | 201.36 Million |
| Depreciation & Amortization | 575.07 Million | 561.1 Million | 550.91 Million | 480.75 Million | 340.38 Million | 322.98 Million |
| Deferred income taxes | -18.88 Million | -7.24 Million | -13.24 Million | 1.34 Million | -889.85 Thousand | -20.55 Million |
| Stock-based compensation | 102.22 Million | 79.77 Million | -1.19 Million | 52.37 Million | 156.93 Million | 13.94 Million |
| Change in working capital | -647.04 Million | 253.96 Million | -113.57 Million | -172.62 Million | -582.4 Million | -656.81 Million |
| Other non-cash items | 2.21 Billion | -136.07 Million | 228.16 Million | 198.24 Million | 268.14 Million | 417.55 Million |
| Investing Cash Flow | -227.96 Million | -256.34 Million | -100.07 Million | -322.66 Million | -232.06 Million | -563.01 Million |
| Investments in PPE | -235.43 Million | -244.12 Million | -119.8 Million | -400.38 Million | -229.16 Million | -565.73 Million |
| Acquisitions | 7.46 Million | 3.17 Million | 7.83 Million | 77.71 Million | -4 Million | 138.52 Thousand |
| Investment purchases | - | - | -500 Million | - | - | - |
| Sales/Maturities of investments | - | - | 15.89 Million | - | - | - |
| Other Investing Activities | 7.46 Million | -15.38 Million | 496 Million | 0.64 | 1.09 Million | 2.58 Million |
| Financing Cash Flow | 381.09 Million | -58.98 Million | -132.38 Million | -359.27 Million | -104.91 Million | -145.22 Million |
| Debt repayment | -1.74 Billion | -3.35 Billion | -4.06 Billion | -4.09 Billion | -4.21 Billion | -5.42 Billion |
| Dividends payments | -142.91 Million | -18.87 Million | -10.78 Million | -124.96 Million | -135.59 Million | -166.55 Million |
| Common Stock Repurchased | -14.21 Million | - | -7.35 Million | - | - | - |
| Common Stock Issuance | - | - | 7.35 Million | - | - | - |
| Other Financing Activities | -1.18 Billion | 3.4 Billion | 4.09 Billion | 3.85 Billion | 4.24 Billion | 5.44 Billion |
| Accounts receivables | 149.05 Million | 115.03 Million | -268.93 Million | 249.18 Million | -79.41 Million | -746.11 Million |
| Accounts payables | -747.7 Million | 151.81 Million | 160.33 Million | -387.76 Million | -396.44 Million | 60.6 Million |
| Inventory | -150.93 Million | -5.64 Million | 8.26 Million | -35.38 Million | -105.66 Million | 49.25 Million |
| Other working capital | 102.54 Million | -7.24 Million | -13.24 Million | 1.34 Million | -889.86 Thousand | -706.07 Million |
| Cash at beginning of period | 3.84 Billion | 1.22 Billion | 708.25 Million | 820.92 Million | 804.73 Million | 1.22 Billion |
| Cash at end of period | 5.65 Billion | 2.02 Billion | 1.22 Billion | 708.25 Million | 820.92 Million | 804.73 Million |
| Capital Expenditure | -235.43 Million | -244.12 Million | -119.8 Million | -400.38 Million | -229.16 Million | -565.73 Million |
| Effect of forex changes on cash | 6.29 Million | 6.91 Million | -1.67 Million | -1.63 Million | 575.25 Thousand | 584.77 Thousand |
| Net cash flow / Change in cash | 1.8 Billion | 800.15 Million | 512.36 Million | -112.66 Million | 16.18 Million | -422.56 Million |
| Free Cash Flow | 351.31 Million | 864.44 Million | 626.69 Million | 170.53 Million | 123.43 Million | -280.64 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 51.15 Million | 99.17 Million | 57.63 Million | 358.45 Million | 138.67 Million | 84.89 Million |
| Depreciation & Amortization | - | 148.21 Million | 148.21 Million | 575.07 Million | 139.71 Million | -291.84 Million |
| Deferred income taxes | - | - | - | -18.88 Million | -102.63 Million | -252.08 Million |
| Stock-based compensation | - | - | - | 102.22 Million | 1.96 Million | 100.25 Million |
| Change in working capital | - | -377.55 Million | - | -647.04 Million | 100.66 Million | 443.66 Million |
| Other non-cash items | 22.56 Million | 308.99 Million | 37.25 Million | 2.21 Billion | -17.74 Million | -24.3 Million |
| Investing Cash Flow | -43.44 Million | -42.42 Million | -49.86 Million | -227.96 Million | -59.31 Million | -70.76 Million |
| Investments in PPE | -43.44 Million | -42.41 Million | -50.24 Million | -235.43 Million | -59.31 Million | -70.76 Million |
| Acquisitions | - | -8330.00 | 377.32 Thousand | 7.46 Million | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -8330.00 | 377.32 Thousand | 7.46 Million | - | - |
| Financing Cash Flow | -494.44 Million | -92.11 Million | 200.69 Million | 381.09 Million | -474.65 Million | 1.09 Billion |
| Debt repayment | -175 Million | -109.02 Million | -210.2 Million | -1.74 Billion | -1.46 Billion | -930 Million |
| Dividends payments | -15.34 Million | -161.03 Million | -17.89 Million | -142.91 Million | -142.91 Million | -143.43 Million |
| Common Stock Repurchased | - | - | - | -14.21 Million | -14.21 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -304.09 Million | 177.94 Million | -9.5 Million | -1.18 Billion | -1.74 Billion | 2.05 Billion |
| Accounts receivables | - | -367.51 Million | - | 149.05 Million | 149.05 Million | 261.41 Million |
| Accounts payables | - | - | - | -747.7 Million | - | 123.87 Million |
| Inventory | - | -36.2 Million | - | -150.93 Million | -150.93 Million | 182.25 Million |
| Other working capital | - | 26.16 Million | - | 102.54 Million | 102.54 Million | -123.87 Million |
| Cash at beginning of period | 3.14 Billion | 3.01 Billion | 5.65 Billion | 3.84 Billion | 4.7 Billion | 1.95 Billion |
| Cash at end of period | 2.66 Billion | 3.14 Billion | 5.81 Billion | 5.65 Billion | 5.65 Billion | 3.04 Billion |
| Capital Expenditure | -43.44 Million | -42.41 Million | -50.24 Million | -235.43 Million | -59.31 Million | -70.76 Million |
| Effect of forex changes on cash | -11.24 Million | 1.34 Million | 1.43 Million | 6.29 Million | -3.01 Million | 426.67 Thousand |
| Net cash flow / Change in cash | -475.4 Million | 126.75 Million | 167.13 Million | 1.8 Billion | 948.19 Million | 1.08 Billion |
| Free Cash Flow | 30.28 Million | 217.53 Million | 44.64 Million | 351.31 Million | 201.34 Million | -10.17 Million |
3147
M3M
ESLT
BYFC
BPCL
FHN-PF